Boston Trust Walden’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-714
Closed -$202K 391
2021
Q3
$202K Buy
+714
New +$202K ﹤0.01% 385
2021
Q1
Sell
-1,349
Closed -$330K 371
2020
Q4
$330K Buy
1,349
+20
+2% +$4.89K ﹤0.01% 342
2020
Q3
$377K Hold
1,329
﹤0.01% 327
2020
Q2
$356K Sell
1,329
-30
-2% -$8.04K ﹤0.01% 328
2020
Q1
$430K Sell
1,359
-20
-1% -$6.33K 0.01% 313
2019
Q4
$409K Sell
1,379
-130
-9% -$38.6K ﹤0.01% 336
2019
Q3
$351K Sell
1,509
-3,610
-71% -$840K ﹤0.01% 343
2019
Q2
$1.2M Sell
5,119
-895
-15% -$209K 0.02% 290
2019
Q1
$1.42M Sell
6,014
-40
-0.7% -$9.45K 0.02% 287
2018
Q4
$1.82M Buy
6,054
+3,445
+132% +$1.04M 0.03% 269
2018
Q3
$922K Buy
2,609
+15
+0.6% +$5.3K 0.01% 309
2018
Q2
$753K Sell
2,594
-100
-4% -$29K 0.01% 313
2018
Q1
$738K Hold
2,694
0.01% 314
2017
Q4
$858K Hold
2,694
0.01% 311
2017
Q3
$844K Sell
2,694
-80
-3% -$25.1K 0.01% 314
2017
Q2
$753K Buy
2,774
+55
+2% +$14.9K 0.01% 309
2017
Q1
$743K Buy
2,719
+54
+2% +$14.8K 0.01% 302
2016
Q4
$756K Sell
2,665
-90
-3% -$25.5K 0.01% 304
2016
Q3
$862K Buy
2,755
+100
+4% +$31.3K 0.01% 296
2016
Q2
$642K Sell
2,655
-325
-11% -$78.6K 0.01% 305
2016
Q1
$776K Sell
2,980
-225
-7% -$58.6K 0.01% 302
2015
Q4
$982K Buy
3,205
+340
+12% +$104K 0.02% 283
2015
Q3
$836K Buy
2,865
+400
+16% +$117K 0.01% 297
2015
Q2
$996K Sell
2,465
-110
-4% -$44.4K 0.02% 289
2015
Q1
$1.09M Sell
2,575
-25
-1% -$10.6K 0.02% 278
2014
Q4
$883K Buy
2,600
+693
+36% +$235K 0.01% 291
2014
Q3
$631K Buy
1,907
+907
+91% +$300K 0.01% 300
2014
Q2
$315K Hold
1,000
﹤0.01% 319
2014
Q1
$306K Hold
1,000
﹤0.01% 305
2013
Q4
$280K Hold
1,000
﹤0.01% 317
2013
Q3
$241K Hold
1,000
﹤0.01% 308
2013
Q2
$215K Buy
+1,000
New +$215K ﹤0.01% 310